Core Insights - The article highlights a significant breakthrough in the field of microecological skincare with the launch of the "IdealSkin Match" data platform by the brand Aier Doctor, in collaboration with Professor Su Xiaoqian's team from Qingdao University, utilizing AI technology and research on ideal skin microbiomes [1][6]. Group 1: Ideal Skin Concept - The "Ideal Skin" concept is defined through a comprehensive understanding of skin microbiomes and physiological parameters, marking a shift from traditional skincare practices to a more scientific approach [2][10]. - Aier Doctor is the first skincare brand in China to establish a database for the ideal skin microbiome, aiming to create a healthy skin state for the Chinese population [10][19]. Group 2: Data Platform and AI Model - The "IdealSkin Match" platform integrates over 9.6 million high-quality facial microbiome gene sequences and more than 19,000 skin physiological parameters, enabling a multidimensional analysis of skin health [10][11]. - The platform employs machine learning algorithms, specifically XGBoost, to enhance the accuracy of skin health assessments, transitioning from experience-based to data-driven skincare management [11][12]. Group 3: Innovation and Research - Aier Doctor has invested in foundational research on skin microbiomes, establishing two databases to explore the correlation between skin microbiomes and physiological parameters [15][16]. - The company has developed innovative products, such as the "287 Barrier Bacteria" technology, which targets the growth of skin barrier bacteria and enhances skin protection [17][18]. Group 4: Industry Impact - The launch of the "IdealSkin Match" platform signifies a milestone in the innovation of microecological skincare products in China, promoting a shift towards intelligent skincare solutions [10][19]. - Aier Doctor's commitment to scientific research and product development positions it as a leader in the Chinese skin microecology industry, contributing to the advancement of skincare technology [19].

Core Insights - The recent technology appraisal meeting organized by Shandong Light Industry Association recognized two significant scientific achievements from Furuida Biopharmaceuticals, marking them as "internationally leading" and "internationally advanced" in the fields of functional skin microbiome and zinc hyaluronate research [1][7]. Group 1: Research Achievements - The project on "Preparation of Zinc Hyaluronate and Its Application in Skincare Products" has successfully overcome technical bottlenecks over a five-year research period, establishing the first domestic detection standard and demonstrating effective targeting of 5α-reductase [3]. - The project has resulted in the publication of 2 scientific papers and the granting of 3 invention patents, filling a research gap in the precise oil control and soothing skincare direction for zinc hyaluronate derivatives [3]. Group 2: Functional Skin Microbiome Research - The project "Research on Functional Skin Microbiome and Development of Functional Care Products" has created a correlation database linking skin microbiome distribution to physiological parameters across different populations, establishing a functional skin microbiome screening platform [5]. - This project has led to the application for 10 invention patents, with 4 granted, and the publication of 7 scientific papers, including 5 in SCI journals, thereby setting a standard in the field of microbiome science in skincare [5]. Group 3: Future Directions - Furuida Biopharmaceuticals aims to continue its deep exploration in the fields of zinc hyaluronate and skin microbiome, establishing itself as a benchmark in the hyaluronate industry and leading the scientific skincare sector [9].